{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:31:19Z","timestamp":1791405079870,"version":"4.3.3"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00296-020-04658-6","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T11:02:58Z","timestamp":1595761378000},"page":"1555-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-8928","authenticated-orcid":false,"given":"Bohdana","family":"Doskaliuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-1273","authenticated-orcid":false,"given":"Liubomyr","family":"Zaiats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-5609","authenticated-orcid":false,"given":"Roman","family":"Yatsyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7708-2150","authenticated-orcid":false,"given":"Petro","family":"Gerych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-847X","authenticated-orcid":false,"given":"Nataliia","family":"Cherniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,26]]},"reference":[{"key":"4658_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S191418","volume":"11","author":"A Bergamasco","year":"2019","unstructured":"Bergamasco A, Hartmann N, Wallace L, Verpillat P (2019) Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol 11:257\u2013273. https:\/\/doi.org\/10.2147\/CLEP.S191418","journal-title":"Clin Epidemiol"},{"issue":"1","key":"4658_CR2","doi-asserted-by":"publisher","first-page":"e37e9","DOI":"10.1111\/bjd.15838","volume":"178","author":"GW Kang","year":"2018","unstructured":"Kang GW, Jung KH, Lee YS, Kim HJ, Yoon DY, Lee SH et al (2018) Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study. Br J Dermatol 178(1):e37e9. https:\/\/doi.org\/10.1111\/bjd.15838","journal-title":"Br J Dermatol"},{"issue":"2","key":"4658_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.berh.2018.08.005","volume":"32","author":"F Ingegnoli","year":"2018","unstructured":"Ingegnoli F, Ughi N, Mihai C (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol 32(2):223\u2013240. https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"4658_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41584-018-0062-0","volume":"14","author":"CP Denton","year":"2018","unstructured":"Denton CP, Wells AU, Coghlan JG (2018) Major lung complications of systemic sclerosis. Nat Rev Rheumatol 14(9):511\u2013527. https:\/\/doi.org\/10.1038\/s41584-018-0062-0","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4658_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Air\u00f2 P, Joven B, Vettori S, Cozzi F (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897\u20131905. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211448","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4658_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","volume":"21","author":"MR Pokeerbux","year":"2019","unstructured":"Pokeerbux MR, Giovannelli J, Dauchet L, Mouthon L, Agard C, Lega JC, Allanore Y, Jego P, Bienvenu B, Berthier S, Mekinian A (2019) Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther 21(1):86. https:\/\/doi.org\/10.1186\/s13075-019-1867-1","journal-title":"Arthritis Res Ther"},{"key":"4658_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4569826","author":"A Sierra-Sep\u00falveda","year":"2019","unstructured":"Sierra-Sep\u00falveda A, Esquinca-Gonz\u00e1lez A, Benavides-Su\u00e1rez SA, Sordo-Lima DE, Caballero-Islas AE, Cabral-Casta\u00f1eda AR, Rodr\u00edguez-Reyna TS (2019) Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast. Biomed Res Int. https:\/\/doi.org\/10.1155\/2019\/4569826","journal-title":"Biomed Res Int"},{"issue":"4","key":"4658_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11926-014-0411-1","volume":"16","author":"T Akter","year":"2014","unstructured":"Akter T, Silver RM, Bogatkevich GS (2014) Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. Curr Rheumatol Rep 16(4):411. https:\/\/doi.org\/10.1007\/s11926-014-0411-1","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"4658_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/BOR.0b013e32833ddcc9","volume":"22","author":"RJ Homer","year":"2010","unstructured":"Homer RJ, Herzog EL (2010) Recent advances in pulmonary fibrosis: implications for scleroderma. Curr Opin Rheumatol 22(6):683\u2013689. https:\/\/doi.org\/10.1097\/BOR.0b013e32833ddcc9","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"4658_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00296-016-3636-7","volume":"15","author":"A Morales-C\u00e1rdenas","year":"2016","unstructured":"Morales-C\u00e1rdenas A, P\u00e9rez-Madrid C, Arias L, Ojeda P, Mahecha MP, Rojas-Villarraga A, Carrillo-Bayona JA, Anaya JM (2016) Pulmonary involvement in systemic sclerosis. Autoimmun Rev 15(11):1094\u20131108. https:\/\/doi.org\/10.1007\/s00296-016-3636-7","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4658_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8(3):304\u2013320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1","journal-title":"Lancet Respir Med"},{"issue":"3","key":"4658_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.31138\/mjr.29.3.140","volume":"29","author":"S Ahmed","year":"2018","unstructured":"Ahmed S, Pattanaik SS, Rai MK, Nath A, Agarwal V (2018) Interstitial lung disease in systemic sclerosis: insights into pathogenesis and evolving therapies. Mediterr J Rheumatol 29(3):140\u2013147. https:\/\/doi.org\/10.31138\/mjr.29.3.140","journal-title":"Mediterr J Rheumatol"},{"issue":"8","key":"4658_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1753465817713680","volume":"11","author":"SR Schoenfeld","year":"2017","unstructured":"Schoenfeld SR, Castelino FV (2017) Evaluation and management approaches for scleroderma lung disease. Ther Adv Respir Dis 11(8):327\u2013340. https:\/\/doi.org\/10.1177\/1753465817713680","journal-title":"Ther Adv Respir Dis"},{"key":"4658_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"6","key":"4658_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","volume":"37","author":"R Giacomelli","year":"2017","unstructured":"Giacomelli R, Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F, Guggino G, Di Bartolomeo S, Ciccia F, Triolo G, Cipriani P (2017) Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int 37(6):853\u2013863. https:\/\/doi.org\/10.1007\/s00296-016-3636-7","journal-title":"Rheumatol Int"},{"issue":"1","key":"4658_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J (2012) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8(1):42. https:\/\/doi.org\/10.1038\/nrrheum.2011.149","journal-title":"Nat Rev Rheumatol"},{"key":"4658_CR17","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N et al (2009) Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 182:5855\u20135864. https:\/\/doi.org\/10.4049\/jimmunol.0803705","journal-title":"J Immunol"},{"key":"4658_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","volume":"112","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Takagawa S, Katayama I et al (1999) Animal model of sclerotic skin. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Investig Dermatol 112:456\u2013462. https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00528.x","journal-title":"J Investig Dermatol"},{"issue":"6","key":"4658_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/art.39084","volume":"67","author":"T Spadoni","year":"2015","unstructured":"Spadoni T, Svegliati Baroni S, Amico D, Albani L, Moroncini G, Avvedimento EV, Gabrielli A (2015) A reactive oxygen species\u2013mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis. Arthritis Rheumatol 67(6):1611\u20131622. https:\/\/doi.org\/10.1002\/art.39084","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jcp.24436","volume":"229","author":"Z Sun","year":"2014","unstructured":"Sun Z, Gong X, Zhu H et al (2014) Inhibition of Wnt\/\u03b2-catenin signaling promotes engraftment of mesenchymal stem cells to repair lung injury. J Cell Physiol 229:213\u2013224. https:\/\/doi.org\/10.1002\/jcp.24436","journal-title":"J Cell Physiol"},{"key":"4658_CR21","doi-asserted-by":"publisher","first-page":"e43049","DOI":"10.1371\/journal.pone.0043049","volume":"7","author":"XD Ruiz","year":"2012","unstructured":"Ruiz XD, Mlakar LR, Yamaguchi Y et al (2012) Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS ONE 7:e43049. https:\/\/doi.org\/10.1371\/journal.pone.0043049","journal-title":"PLoS ONE"},{"issue":"12","key":"4658_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R (2014) Transforming growth factor \u03b2\u2014at the centre of systemic sclerosis. Nat Rev Rheumatol 10(12):706\u2013719. https:\/\/doi.org\/10.1038\/nrrheum.2014.137","journal-title":"Nat Rev Rheumatol"},{"issue":"21","key":"4658_CR23","doi-asserted-by":"publisher","first-page":"14824","DOI":"10.1074\/jbc.M113.451336","volume":"288","author":"AC Midgley","year":"2013","unstructured":"Midgley AC, Rogers M, Hallett MB, Clayton A, Bowen T, Phillips AO, Steadman R (2013) Transforming growth factor-\u03b21 (TGF-\u03b21)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem 288(21):14824\u201314838. https:\/\/doi.org\/10.1074\/jbc.M113.451336","journal-title":"J Biol Chem"},{"issue":"1","key":"4658_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-015-0708-0","volume":"17","author":"J Baraut","year":"2015","unstructured":"Baraut J, Farge D, Jean-Louis F, Masse I, Grigore EI, Arruda LC, Lamartine J, Verrecchia F, Michel L (2015) Transforming growth factor-\u03b2 increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis. Arthritis Res Ther 17(1):196. https:\/\/doi.org\/10.1186\/s13075-015-0708-0","journal-title":"Arthritis Res Ther"},{"key":"4658_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/09031936.00152106","volume":"29","author":"NI Chaudhary","year":"2007","unstructured":"Chaudhary NI, Roth GJ, Hilberg F et al (2007) Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J 29:976\u2013985. https:\/\/doi.org\/10.1183\/09031936.00152106","journal-title":"Eur Respir J"},{"key":"4658_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","volume":"49","author":"H Ihn","year":"2008","unstructured":"Ihn H (2008) Autocrine TGF-\u03b2 signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49:103\u2013113. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.05.014","journal-title":"J Dermatol Sci"},{"issue":"6","key":"4658_CR27","doi-asserted-by":"publisher","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","volume":"122","author":"SH Phan","year":"2002","unstructured":"Phan SH (2002) The myofibroblast in pulmonary fibrosis. Chest 122(6):286S\u2013289S. https:\/\/doi.org\/10.1378\/chest.122.6_suppl.286S","journal-title":"Chest"},{"issue":"25","key":"4658_CR28","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354(25):2667\u20132676. https:\/\/doi.org\/10.1056\/NEJMoa052955","journal-title":"N Engl J Med"},{"issue":"10","key":"4658_CR29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","volume":"78","author":"E Valenzi","year":"2019","unstructured":"Valenzi E, Bulik M, Tabib T, Morse C, Sembrat J, Bittar HT, Rojas M, Lafyatis R (2019) Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis 78(10):1379\u20131387. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214865","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"4658_CR30","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380(26):2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"},{"issue":"9","key":"4658_CR31","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/annrheumdis-2019-215119","volume":"78","author":"A Mor","year":"2019","unstructured":"Mor A, Salto MS, Katav A, Barashi N, Edelshtein V, Manetti M, Levi Y, George J, Matucci-Cerinic M (2019) Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis. Ann Rheum Dis 78(9):1260\u20131268. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215119","journal-title":"Ann Rheum Dis"},{"key":"4658_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04485-4","author":"AA Kilinc","year":"2019","unstructured":"Kilinc AA, Arslan A, Yildiz M et al (2019) Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-019-04485-4","journal-title":"Rheumatol Int"},{"issue":"9","key":"4658_CR33","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/rheumatology\/kez230","volume":"58","author":"O Bonhomme","year":"2019","unstructured":"Bonhomme O, Andr\u00e9 B, Gester F, de Seny D, Moermans C, Struman I, Louis R, Malaise M, Guiot J (2019) Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology 58(9):1534\u20131546. https:\/\/doi.org\/10.1093\/rheumatology\/kez230","journal-title":"Rheumatology"},{"issue":"2","key":"4658_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15406\/mojcrr.2018.01.00009","volume":"1","author":"B Menon","year":"2018","unstructured":"Menon B, Tiwari M, Gopi A, Raj P, Panwar K (2018) Serum Krebs von den Lungen-6 (KL-6): a promising biomarker in sarcoidosis. MOJ Curr Res Rev 1(2):1. https:\/\/doi.org\/10.15406\/mojcrr.2018.01.00009","journal-title":"MOJ Curr Res Rev"},{"key":"4658_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11739-020-02281-8","volume":"20","author":"N Lanzarone","year":"2020","unstructured":"Lanzarone N, Gentili F, Alonzi V, Bergantini L, d\u2019Alessandro M, Rottoli P, Refini RM, Pieroni M, Vietri L, Bianchi F, Mazzei MA (2020) Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features. Intern Emerg Med 20:1\u20138. https:\/\/doi.org\/10.1007\/s11739-020-02281-8","journal-title":"Intern Emerg Med"},{"key":"4658_CR36","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1007\/s10067-015-3167-8","volume":"35","author":"EO Oguz","year":"2016","unstructured":"Oguz EO, Kucuksahin O, Turgay M et al (2016) Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Clin Rheumatol 35:6636. https:\/\/doi.org\/10.1007\/s10067-015-3167-8","journal-title":"Clin Rheumatol"},{"key":"4658_CR37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3899\/jrheum.160339","volume":"43","author":"M Kuwana","year":"2016","unstructured":"Kuwana M, Shirai Y, Takeuchi T (2016) Elevated serum Krebs von den Lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease. J Rheumatol 43:1825\u20131831. https:\/\/doi.org\/10.3899\/jrheum.160339","journal-title":"J Rheumatol"},{"issue":"5","key":"4658_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-018-3987-3","volume":"38","author":"A Benyamine","year":"2018","unstructured":"Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, Harl\u00e9 JR, Kaplanski G, Rossi P, Bardin N, Granel B (2018) Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Rheumatol Int 38(5):813\u2013819. https:\/\/doi.org\/10.1007\/s00296-018-3987-3","journal-title":"Rheumatol Int"},{"key":"4658_CR39","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.40815","volume":"71","author":"M Elhai","year":"2019","unstructured":"Elhai M, Hoffmann-Vold AM, Avouac J et al (2019) Performance of candidate serum biomarkers for systemic sclerosis associated-interstitial lung disease. Arthritis Rheumatol 71:972\u2013982. https:\/\/doi.org\/10.1002\/art.40815","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR40","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.2169\/internalmedicine.50.5866","volume":"50","author":"S Doishita","year":"2011","unstructured":"Doishita S, Inokuma S, Asashima H et al (2011) Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases. Intern Med 50:2889\u20132892. https:\/\/doi.org\/10.2169\/internalmedicine.50.5866","journal-title":"Intern Med"},{"issue":"8","key":"4658_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3899\/jrheum.170518","volume":"45","author":"GA Salazar","year":"2018","unstructured":"Salazar GA, Kuwana M, Wu M, Estrada-Y-Martin RM, Ying J, Charles J, Mayes MD, Assassi S (2018) KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease. J Rheumatol 45(8):1153\u20131158. https:\/\/doi.org\/10.3899\/jrheum.170518","journal-title":"J Rheumatol"},{"issue":"6","key":"4658_CR42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","volume":"44","author":"Y Asano","year":"2001","unstructured":"Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K (2001) Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheumatol 44(6):1363\u20131369. https:\/\/doi.org\/10.1002\/1529-0131(200106)44:6%3c1363:AID-ART229%3e3.0.CO;2-5","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3899\/jrheum.080633","volume":"3636","author":"FN Hant","year":"2009","unstructured":"Hant FN, Ludwicka-Bradley A, Wang H-J et al (2009) Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol 3636:773\u2013780. https:\/\/doi.org\/10.3899\/jrheum.080633","journal-title":"J Rheumatol"},{"key":"4658_CR44","first-page":"1112","volume":"31","author":"Y Koichi","year":"2004","unstructured":"Koichi Y, Minoru H, Kazuhiko T, Shinichi S (2004) Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers of monitoring activity of pulmonary fibrosis. J Rheumatol 31:1112\u20131120","journal-title":"J Rheumatol"},{"issue":"2","key":"4658_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.21037\/jtd.2017.02.48","volume":"9","author":"H Yamakawa","year":"2017","unstructured":"Yamakawa H, Hagiwara E, Kitamura H, Yamanaka Y, Ikeda S, Sekine A, Baba T, Okudela K, Iwasawa T, Takemura T, Kuwano K (2017) Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease. J Thorac Dis 9(2):362\u2013371. https:\/\/doi.org\/10.21037\/jtd.2017.02.48","journal-title":"J Thorac Dis"},{"issue":"1","key":"4658_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1164\/ajrccm.162.1.9903014","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S (2000) Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 162(1):258\u2013263. https:\/\/doi.org\/10.1164\/ajrccm.162.1.9903014","journal-title":"Am J Respir Crit Care Med"},{"key":"4658_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.molimm.2018.05.004","volume":"101","author":"C Yan","year":"2018","unstructured":"Yan C, Deng C, Liu X, Chen Y, Ye J, Cai R, Shen Y, Tang H (2018) TNF-\u03b1 induction of IL-6 in alveolar type II epithelial cells: contributions of JNK\/c-Jun\/AP-1 element, C\/EBP\u03b4\/C\/EBP binding site and IKK\/NF-\u03baB p65\/\u03baB site. Mol Immunol 101:585\u2013596. https:\/\/doi.org\/10.1016\/j.molimm.2018.05.004","journal-title":"Mol Immunol"},{"issue":"5","key":"4658_CR48","doi-asserted-by":"publisher","first-page":"e0126763","DOI":"10.1371\/journal.pone.0126763","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD, Stewart N, Horne J, Peterson GM, Gueven N, Sohal SS, Patel RP (2015) In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin. PLoS One 10(5):e0126763. https:\/\/doi.org\/10.1371\/journal.pone.0126763","journal-title":"PLoS One"},{"issue":"1","key":"4658_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12931-016-0483-8","volume":"18","author":"SD Shukla","year":"2017","unstructured":"Shukla SD, Mahmood MQ, Weston S, Latham R, Muller HK, Sohal SS, Walters EH (2017) The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL). Respir Res 18(1):6. https:\/\/doi.org\/10.1186\/s12931-016-0483-8","journal-title":"Respir Res"},{"issue":"1","key":"4658_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/resp.12149","volume":"19","author":"H Kuhn","year":"2014","unstructured":"Kuhn H, Petzold K, Hammerschmidt S, Wirtz H (2014) Interaction of cyclic mechanical stretch and toll-like receptor 4-mediated innate immunity in rat alveolar type II cells. Respirology 19(1):67\u201373. https:\/\/doi.org\/10.1111\/resp.12149","journal-title":"Respirology"},{"issue":"1","key":"4658_CR51","doi-asserted-by":"publisher","first-page":"e55545","DOI":"10.1371\/journal.pone.0055545","volume":"8","author":"MH Wong","year":"2013","unstructured":"Wong MH, Johnson MD (2013) Differential response of primary alveolar type I and type II cells to LPS stimulation. PLoS ONE 8(1):e55545. https:\/\/doi.org\/10.1371\/journal.pone.0055545","journal-title":"PLoS ONE"},{"issue":"7","key":"4658_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bmt.1704616","volume":"34","author":"YC Shen","year":"2004","unstructured":"Shen YC, Chiu CF, Chow KC, Chen CL, Liaw YC, Yeh SP (2004) Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-\u03b2 1 and cyclooxygenase-2. Bone Marrow Transpl 34(7):609\u2013614. https:\/\/doi.org\/10.1038\/sj.bmt.1704616","journal-title":"Bone Marrow Transpl"},{"key":"4658_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2559.1994.tb01293.x","volume":"24","author":"B Corrin","year":"1994","unstructured":"Corrin B, Butcher D, McAnulty BJ, Du Bois RM, Black CM, Laurent GJ, Harrison NK (1994) Immunohistochemical localization of transforming growth factor-b1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 24:145\u2013150. https:\/\/doi.org\/10.1111\/j.1365-2559.1994.tb01293.x","journal-title":"Histopathology"},{"issue":"8","key":"4658_CR54","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jid.2017.03.032","volume":"137","author":"K Makino","year":"2017","unstructured":"Makino K, Makino T, Stawski L, Mantero JC, Lafyatis R, Simms R, Trojanowska M (2017) Blockade of PDGF receptors by crenolanib has therapeutic effect in patient fibroblasts and in preclinical models of systemic sclerosis. J Investig Dermatol 137(8):1671\u20131681. https:\/\/doi.org\/10.1016\/j.jid.2017.03.032","journal-title":"J Investig Dermatol"},{"issue":"5","key":"4658_CR55","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.ajpath.2011.01.035","volume":"178","author":"F Fang","year":"2011","unstructured":"Fang F, Ooka K, Bhattachyya S, Wei J, Wu M, Du P, Lin S, Del Galdo F, Feghali-Bostwick CA, Varga J (2011) The early growth response gene Egr2 (alias Krox20) is a novel transcriptional target of transforming growth factor-\u03b2 that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol 178(5):2077\u20132090. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.035","journal-title":"Am J Pathol"},{"issue":"4","key":"4658_CR56","doi-asserted-by":"publisher","first-page":"e95013","DOI":"10.1371\/journal.pone.0095013","volume":"9","author":"F Novelli","year":"2014","unstructured":"Novelli F, Neri T, Tavanti L, Armani C, Noce C, Falaschi F, Bartoli ML, Martino F, Palla A, Celi A, Paggiaro P (2014) Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study. PloS One 9(4):e95013. https:\/\/doi.org\/10.1371\/journal.pone.0095013","journal-title":"PloS One"},{"issue":"1","key":"4658_CR57","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12931-018-0841-9","volume":"19","author":"T Goldmann","year":"2018","unstructured":"Goldmann T, Zissel G, Watz H et al (2018) Human alveolar epithelial cells type II are capable of TGF\u03b2-dependent epithelial-mesenchymal-transition and collagen-synthesis. Respir Res 19(1):138. https:\/\/doi.org\/10.1186\/s12931-018-0841-9","journal-title":"Respir Res"},{"issue":"135","key":"4658_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.00003214","volume":"24","author":"G Bagnato","year":"2015","unstructured":"Bagnato G, Harari S (2015) Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24(135):102\u2013114. https:\/\/doi.org\/10.1183\/09059180.00003214","journal-title":"Eur Respir Rev"},{"key":"4658_CR59","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1165\/rcmb.2010-0113OC","volume":"45","author":"AP Lam","year":"2011","unstructured":"Lam AP, Flozak AS, Russell S et al (2011) Nuclear \u03b2-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol 45:915\u2013922","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"4658_CR60","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1242\/dev.129122","volume":"143","author":"SY Tan","year":"2016","unstructured":"Tan SY, Krasnow MA (2016) Developmental origin of lung macrophage diversity. Development 143(8):1318\u20131327. https:\/\/doi.org\/10.1242\/dev.129122","journal-title":"Development"},{"issue":"6","key":"4658_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/BOR.0000000000000657","volume":"31","author":"S To","year":"2019","unstructured":"To S, Agarwal SK (2019) Macrophages and cadherins in fibrosis and systemic sclerosis. Curr Opin Rheumatol 31(6):582\u2013588. https:\/\/doi.org\/10.1097\/BOR.0000000000000657","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"4658_CR62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958\u2013969. https:\/\/doi.org\/10.1038\/nri2448","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4658_CR63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00296-018-4120-3","volume":"39","author":"S Bhattacharya","year":"2019","unstructured":"Bhattacharya S, Aggarwal A (2019) M2 macrophages and their role in rheumatic diseases. Rheumatol Int 39(5):769\u2013780. https:\/\/doi.org\/10.1007\/s00296-018-4120-3","journal-title":"Rheumatol Int"},{"key":"4658_CR64","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","volume":"12","author":"N Higashi-Kuwata","year":"2010","unstructured":"Higashi-Kuwata N, Jinnin M, Makino T et al (2010) Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12:R128. https:\/\/doi.org\/10.1186\/ar3066","journal-title":"Arthritis Res Ther"},{"key":"4658_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR et al (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229:176\u2013185. https:\/\/doi.org\/10.1002\/path.4133","journal-title":"J Pathol"},{"issue":"3","key":"4658_CR66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.21037\/jtd.2017.02.50","volume":"9","author":"X Zhu","year":"2017","unstructured":"Zhu X, Fang X, Chen W, Han F, Huang Z, Luo B, Gu P, Zhang L, Qiu W, Zeng Y, Rui W (2017) Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia. J Thorac Dis 9(3):519\u2013528. https:\/\/doi.org\/10.21037\/jtd.2017.02.50","journal-title":"J Thorac Dis"},{"issue":"2","key":"4658_CR67","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3892\/mmr.2018.9726","volume":"19","author":"J He","year":"2019","unstructured":"He J, Mu M, Wang H, Ma H, Tang X, Fang Q, Guo S, Song C (2019) Upregulated IGF-1 in the lungs of asthmatic mice originates from alveolar macrophages. Mol Med Rep 19(2):1266\u20131271. https:\/\/doi.org\/10.3892\/mmr.2018.9726","journal-title":"Mol Med Rep"},{"issue":"1","key":"4658_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","volume":"18","author":"G Stifano","year":"2016","unstructured":"Stifano G, Christmann RB (2016) Macrophage involvement in systemic sclerosis: do we need more evidence? Curr Rheumatol Rep 18(1):2. https:\/\/doi.org\/10.1007\/s11926-015-0554-8","journal-title":"Curr Rheumatol Rep"},{"key":"4658_CR69","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/annrheumdis-2017-212454","volume":"77","author":"A Moreno-Moral","year":"2018","unstructured":"Moreno-Moral A, Bagnati M, Koturan S, Ko JH, Fonseca C, Harmston N et al (2018) Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk. Ann Rheum Dis 77:596\u2013601. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212454","journal-title":"Ann Rheum Dis"},{"key":"4658_CR70","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1136\/annrheumdis-2018-213112","volume":"78","author":"A Lescoat","year":"2018","unstructured":"Lescoat A, J\u00e9go P, Lecureur V (2018) M-CSF and GM-CSF monocyte-derived macrophages in systemic sclerosis: the two sides of the same coin? Ann Rheum Dis 78:e19. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213112","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4658_CR71","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","volume":"12","author":"N Higashi-Kuwata","year":"2010","unstructured":"Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, Yonemura Y, Komohara Y, Takeya M, Mitsuya H, Ihn H (2010) Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12(4):R128. https:\/\/doi.org\/10.1186\/ar3066","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4658_CR72","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/art.22559","volume":"56","author":"A Prasse","year":"2007","unstructured":"Prasse A, Pechkovsky DV, Toews GB, Schafer M, Eggeling S, Ludwig C et al (2007) CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheumatol 56(5):1685\u20131693. https:\/\/doi.org\/10.1002\/art.22559","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"4658_CR73","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1183\/09031936.00131713","volume":"43","author":"J Schupp","year":"2014","unstructured":"Schupp J, Becker M, Gunther J, Muller-Quernheim J, Riemekasten G, Prasse A (2014) Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis. Eur Respir J 43(5):1530\u20131532. https:\/\/doi.org\/10.1183\/09031936.00131713","journal-title":"Eur Respir J"},{"issue":"6","key":"4658_CR74","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1183\/09031936.00004711","volume":"38","author":"KP Tiev","year":"2011","unstructured":"Tiev KP, Hua-Huy T, Kettaneh A, GainM Duong-Quy S, Toledano C et al (2011) Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis. Eur Respir J 38(6):1355\u20131360. https:\/\/doi.org\/10.1183\/09031936.00004711","journal-title":"Eur Respir J"},{"key":"4658_CR75","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","volume":"19","author":"AC Trombetta","year":"2018","unstructured":"Trombetta AC, Soldano S, Contini P et al (2018) A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res 19:186. https:\/\/doi.org\/10.1186\/s12931-018-0891-z","journal-title":"Respir Res"},{"key":"4658_CR76","doi-asserted-by":"publisher","first-page":"e0205702","DOI":"10.1371\/journal.pone.0205702","volume":"13","author":"K Otsuka","year":"2018","unstructured":"Otsuka K, Yamada K, Taquahashi Y et al (2018) Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multiwall carbon nanotubes. PLoS ONE 13:e0205702. https:\/\/doi.org\/10.1371\/journal.pone.0205702","journal-title":"PLoS ONE"},{"key":"4658_CR77","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1165\/rcmb.2017-0154OC","volume":"58","author":"AL McCubbrey","year":"2018","unstructured":"McCubbrey AL, Barthel L, Mohning MP et al (2018) Deletion of c-FLIP from CD11b hi macrophages prevents development of bleomycin-induced lung fibrosis. Am J Respir Cell Mol Biol 58:66\u201378. https:\/\/doi.org\/10.1165\/rcmb.2017-0154OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"4658_CR78","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4049\/jimmunol.1800883","volume":"203","author":"PA Nicolosi","year":"2019","unstructured":"Nicolosi PA, Tombetti E, Giovenzana A, Don\u00e8 E, Pulcinelli E, Meneveri R, Tirone M, Maugeri N, Rovere-Querini P, Manfredi AA, Brunelli S (2019) Macrophages guard endothelial lineage by hindering endothelial-to-mesenchymal transition: implications for the pathogenesis of Systemic Sclerosis. J Immunol 203(1):247\u2013258. https:\/\/doi.org\/10.4049\/jimmunol.1800883","journal-title":"J Immunol"},{"issue":"8","key":"4658_CR79","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.4049\/jimmunol.1701542","volume":"200","author":"C Sun","year":"2018","unstructured":"Sun C, Chen SY (2018) RGC32 promotes bleomycin-induced systemic sclerosis in a murine disease model by modulating classically activated macrophage function. J Immunol 200(8):2777\u20132785. https:\/\/doi.org\/10.4049\/jimmunol.1701542","journal-title":"J Immunol"},{"key":"4658_CR80","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","volume":"387","author":"D Khanna","year":"2016","unstructured":"Khanna D, Denton CP, Jahreis A et al (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet 387:2630\u20132640. https:\/\/doi.org\/10.1016\/S0140-6736(16)00232-4","journal-title":"Lancet"},{"issue":"7","key":"4658_CR81","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen P, Fillatreau S (2015) Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol 15(7):441\u2013451. https:\/\/doi.org\/10.1038\/nri3857","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4658_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","volume":"55","author":"T Matsushita","year":"2016","unstructured":"Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M (2016) Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity. Rheumatology 55(2):263\u2013267. https:\/\/doi.org\/10.1093\/rheumatology\/kev331","journal-title":"Rheumatology"},{"issue":"7","key":"4658_CR83","doi-asserted-by":"publisher","first-page":"eaas9944","DOI":"10.1126\/sciadv.aas9944","volume":"4","author":"T Matsushita","year":"2018","unstructured":"Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M (2018) BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance. Sci Adv 4(7):eaas9944. https:\/\/doi.org\/10.1126\/sciadv.aas9944","journal-title":"Sci Adv"},{"issue":"8","key":"4658_CR84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the TH 1\/TH 2 paradigm. Nat Rev Immunol 4(8):583\u2013594. https:\/\/doi.org\/10.1038\/nri1412","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4658_CR85","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/art.23406","volume":"58","author":"F Boin","year":"2008","unstructured":"Boin F, De Fanis U, Bartlett SJ, Wigley FM, Rosen A, Casolaro V (2008) T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheumatol 58(4):1165\u20131174. https:\/\/doi.org\/10.1002\/art.23406","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","volume":"184","author":"E Ugor","year":"2017","unstructured":"Ugor E, Simon D, Almanzar G, Pap R, Najbauer J, N\u00e9meth P, Balogh P, Prelog M, Czirj\u00e1k L, Berki T (2017) Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis. J Clin Immunol 184:54\u201362. https:\/\/doi.org\/10.1016\/j.clim.2017.05.013","journal-title":"J Clin Immunol"},{"issue":"1","key":"4658_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-016-0993-2","volume":"18","author":"A Fava","year":"2016","unstructured":"Fava A, Cimbro R, Wigley FM, Liu QR, Rosen A, Boin F (2016) Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma. Arthritis Res Ther 18(1):99. https:\/\/doi.org\/10.1186\/s13075-016-0993-2","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4658_CR88","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00296-019-04317-5","volume":"39","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Misra DP, Agarwal V (2019) Interleukin-17 pathways in systemic sclerosis-associated fibrosis. Rheumatol Int 39(7):1135\u20131143. https:\/\/doi.org\/10.1007\/s00296-019-04317-5","journal-title":"Rheumatol Int"},{"issue":"5","key":"4658_CR89","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"ME Truchetet","year":"2011","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13(5):R166. https:\/\/doi.org\/10.1186\/ar3486","journal-title":"Arthritis Res Ther"},{"key":"4658_CR90","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","volume":"116","author":"J Hur","year":"2007","unstructured":"Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS (2007) Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116:1671\u20131682. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.694778","journal-title":"Circulation"},{"key":"4658_CR91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcmd.2009.10.009","volume":"44","author":"EJ Kushner","year":"2010","unstructured":"Kushner EJ, MacEneaney OJ, Morgan RG, Van Engelenburg AM, Van Guilder GP, DeSouza CA (2010) CD31+ T cells represent a functionally distinct vascular T cell phenotype. Blood Cells Mol Dis 44:74\u201378. https:\/\/doi.org\/10.1016\/j.bcmd.2009.10.009","journal-title":"Blood Cells Mol Dis"},{"key":"4658_CR92","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.intimp.2020.106282","volume":"81","author":"T Lv","year":"2020","unstructured":"Lv T, Yang F, Zhang K, Lv M, Zhang Y, Zhu P (2020) The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis. Int Immunopharmacol 81:1062\u20131082. https:\/\/doi.org\/10.1016\/j.intimp.2020.106282","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4658_CR93","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00296-018-4001-9","volume":"38","author":"ZM \u0141ukasik","year":"2018","unstructured":"\u0141ukasik ZM, Makowski M, Makowska JS (2018) From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. Rheumatol Int 38(6):959\u2013974. https:\/\/doi.org\/10.1007\/s00296-018-4001-9","journal-title":"Rheumatol Int"},{"issue":"1","key":"4658_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10753-013-9716-x","volume":"37","author":"S Soydinc","year":"2014","unstructured":"Soydinc S, Turkbeyler IH, Pehlivan Y, Soylu G, Goktepe MF, Bilici M, Zengin O, Kisacik B, Onat AM (2014) Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis. Inflammation 37(1):100\u2013106. https:\/\/doi.org\/10.1007\/s10753-013-9716-x","journal-title":"Inflammation"},{"issue":"3","key":"4658_CR95","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/ard.2004.022970","volume":"64","author":"O Kowal-Bielecka","year":"2005","unstructured":"Kowal-Bielecka O, Kowal K, Lewszuk A, Bodzenta-Lukaszyk A, Walecki J, Sierakowski S (2005) \u03b2 Thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann Rheum Dis 64(3):484\u2013486. https:\/\/doi.org\/10.1136\/ard.2004.022970","journal-title":"Ann Rheum Dis"},{"key":"4658_CR96","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00296-020-04604-6","volume":"40","author":"A Kim","year":"2020","unstructured":"Kim A, Kim Y, Kim GT, Ahn E, So MW, Sohn DH, Lee SG (2020) Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of data from a prospective cohort study. Rheumatol Int 40:1071\u20131079. https:\/\/doi.org\/10.1007\/s00296-020-04604-6","journal-title":"Rheumatol Int"},{"issue":"1","key":"4658_CR97","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/eci.12018","volume":"43","author":"S Nadaud","year":"2013","unstructured":"Nadaud S, Poirier O, Girerd B, Blanc C, Montani D, Eyries M, Imbert-Bismut F, Pacheco A, Vigne J, Tregouet DA, Humbert M (2013) Small platelet microparticle levels are increased in pulmonary arterial hypertension. Eur J Clin Investig 43(1):64\u201371. https:\/\/doi.org\/10.1111\/eci.12018","journal-title":"Eur J Clin Investig"},{"key":"4658_CR98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L et al (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370:433\u2013443. https:\/\/doi.org\/10.1056\/NEJMoa1114576","journal-title":"N Engl J Med"},{"issue":"3","key":"4658_CR99","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.semarthrit.2017.05.004","volume":"47","author":"K Ntelis","year":"2017","unstructured":"Ntelis K, Solomou EE, Sakkas L, Liossis SN, Daoussis D (2017) The role of platelets in autoimmunity, vasculopathy, and fibrosis: implications for systemic sclerosis. Semin Arthritis Rheumatol 47(3):409\u2013417. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.004","journal-title":"Semin Arthritis Rheumatol"},{"issue":"10","key":"4658_CR100","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","volume":"184","author":"L Ciuclan","year":"2011","unstructured":"Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, Walker C (2011) A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 184(10):1171\u20131182. https:\/\/doi.org\/10.1164\/rccm.201103-0412OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4658_CR101","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.RES.0000215809.47923.fd","volume":"98","author":"L Long","year":"2006","unstructured":"Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98(6):818\u2013827. https:\/\/doi.org\/10.1161\/01.RES.0000215809.47923.fd","journal-title":"Circ Res"},{"key":"4658_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12891-016-1072-1","volume":"17","author":"K Ntelis","year":"2016","unstructured":"Ntelis K, Gkizas V, Filippopoulou A, Davlouros P, Alexopoulos D, Andonopoulos AP, Daoussis D (2016) Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study. BMC Musculoskelet Disord 17:213. https:\/\/doi.org\/10.1186\/s12891-016-1072-1","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4658_CR103","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00378.2006","volume":"293","author":"E Arciniegas","year":"2007","unstructured":"Arciniegas E, Frid MG, Douglas IS, Stenmark KR (2007) Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293(1):L1\u2013L8. https:\/\/doi.org\/10.1152\/ajplung.00378.2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"4658_CR104","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/labinvest.2017.23","volume":"97","author":"PJ Wermuth","year":"2017","unstructured":"Wermuth PJ, Carney KR, Mendoza FA, Piera-Velazquez S, Jimenez SA (2017) Endothelial cell-specific activation of transforming growth factor-\u03b2 signaling in mice induces cutaneous, visceral, and microvascular fibrosis. Lab Investig 97(7):806\u2013818. https:\/\/doi.org\/10.1038\/labinvest.2017.23","journal-title":"Lab Investig"},{"issue":"1","key":"4658_CR105","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.39421","volume":"68","author":"FA Mendoza","year":"2016","unstructured":"Mendoza FA, Piera-Velazquez S, Farber JL, Feghali-Bostwick C, Jimenez SA (2016) Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol 68(1):210\u2013217. https:\/\/doi.org\/10.1002\/art.39421","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"4658_CR106","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","volume":"185","author":"RB Good","year":"2015","unstructured":"Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ, Holmes AM (2015) Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol 185(7):1850\u20131858. https:\/\/doi.org\/10.1016\/j.ajpath.2015.03.019","journal-title":"Am J Pathol"},{"key":"4658_CR107","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1002\/art.38078","volume":"65","author":"EC Derrett-Smith","year":"2013","unstructured":"Derrett-Smith EC, Dooley A, Gilbane A, Trinder S, Khan K, Baliga R, Holmes A, Hobbs A, Abraham D, Denton CP (2013) Endothelial injury in a transforming growth factor b-dependent mouse model of scleroderma induces pulmonary arterial hypertension. Arthritis Rheumatol 65:2928\u20132939. https:\/\/doi.org\/10.1002\/art.38078","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4658_CR108","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","volume":"18","author":"CF Kuo","year":"2016","unstructured":"Kuo CF, Luo SF, Yu KH, See LC, Zhang W, Doherty M (2016) Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families. Arthritis Res Ther 18(1):231. https:\/\/doi.org\/10.1186\/s13075-016-1127-6","journal-title":"Arthritis Res Ther"},{"key":"4658_CR109","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheumatol 48:1956\u20131963. https:\/\/doi.org\/10.1002\/art.11173","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"4658_CR110","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41584-018-0021-9","volume":"14","author":"PJ Wermuth","year":"2018","unstructured":"Wermuth PJ, Piera-Velazquez S, Rosenbloom J, Jimenez SA (2018) Existing and novel biomarkers for precision medicine in systemic sclerosis. Nat Rev Rheumatol 14(7):421\u2013432. https:\/\/doi.org\/10.1038\/s41584-018-0021-9","journal-title":"Nat Rev Rheumatol"},{"key":"4658_CR111","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano A et al (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS ONE 3:e2696. https:\/\/doi.org\/10.1371\/journal.pone.0002696","journal-title":"PLoS ONE"},{"issue":"11","key":"4658_CR112","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41584-018-0099-0","volume":"14","author":"C Angiolilli","year":"2018","unstructured":"Angiolilli C, Marut W, van der Kroef M, Chouri E, Reedquist KA, Radstake TR (2018) New insights into the genetics and epigenetics of systemic sclerosis. Nat Rev Rheumatol 14(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41584-018-0099-0","journal-title":"Nat Rev Rheumatol"},{"key":"4658_CR113","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.39730","volume":"68","author":"E Lopez-Isac","year":"2016","unstructured":"Lopez-Isac E et al (2016) Brief report: IRF4 newly identified as a common susceptibility locus for systemic sclerosis and rheumatoid arthritis in a cross-disease meta-analysis of genome-wide association studies. Arthritis Rheumatol 68:2338\u20132344. https:\/\/doi.org\/10.1002\/art.39730","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR114","doi-asserted-by":"publisher","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004133","volume":"11","author":"JM Mahoney","year":"2015","unstructured":"Mahoney JM et al (2015) Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput Biol 11:e1004005. https:\/\/doi.org\/10.1371\/journal.pcbi.1004133","journal-title":"PLoS Comput Biol"},{"key":"4658_CR115","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/art.27220","volume":"62","author":"G Farina","year":"2010","unstructured":"Farina G, Lafyatis D, Lemaire R, Lafyatis R (2010) A four- gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 62:580\u2013588. https:\/\/doi.org\/10.1002\/art.27220","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4658_CR116","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.38288","volume":"66","author":"RB Christmann","year":"2014","unstructured":"Christmann RB, Sampaio-Barros P, Stifano G, Borges CL, De Carvalho CR, Kairalla R, Parra ER, Spira A, Simms R, Capellozzi VL, Lafyatis R (2014) Association of interferon-and transforming growth factor \u03b2\u2013regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheumatol 66(3):714\u2013725. https:\/\/doi.org\/10.1002\/art.38288","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR117","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1183\/09031936.00004711","volume":"38","author":"KP Tiev","year":"2011","unstructured":"Tiev KP, Hua-Huy T, Kettaneh A, Gain M, Duong-Quy S, Toledano C et al (2011) Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis. Eur Respir J 38:1355\u20131360. https:\/\/doi.org\/10.1183\/09031936.00004711","journal-title":"Eur Respir J"},{"issue":"3","key":"4658_CR118","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/art.30159","volume":"63","author":"E Hsu","year":"2011","unstructured":"Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheumatol 63(3):783\u2013794","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR119","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1161\/CIRCRESAHA.108.171264","volume":"102","author":"PJ Bernal","year":"2008","unstructured":"Bernal PJ, Leelavanichkul K, Bauer E, Cao R, Wilson A, Wasserloos KJ et al (2008) Nitric oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone. Circ Res 102:1575\u20131583. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.171264","journal-title":"Circ Res"},{"key":"4658_CR120","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ijd.12839","volume":"55","author":"Y Xu","year":"2016","unstructured":"Xu Y, Wang W, Tian Y, Liu J, Yang R (2016) Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis. Int J Dermatol 55:408\u2013416. https:\/\/doi.org\/10.1111\/ijd.12839","journal-title":"Int J Dermatol"},{"key":"4658_CR121","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/art.39721","volume":"68","author":"AC Mak","year":"2016","unstructured":"Mak AC et al (2016) Brief report: whole-exome sequencing for identification of potential causal variants for diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 68:2257\u20132262. https:\/\/doi.org\/10.1002\/art.39721","journal-title":"Arthritis Rheumatol"},{"key":"4658_CR122","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.4238\/2014.june.16.6","volume":"13","author":"L Tang","year":"2014","unstructured":"Tang L, Chen B, Ma B, Nie S (2014) Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis. Genet Mol Res 13:4473\u20134485. https:\/\/doi.org\/10.4238\/2014.june.16.6","journal-title":"Genet Mol Res"},{"key":"4658_CR123","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/039463201402700420","volume":"27","author":"J Wang","year":"2014","unstructured":"Wang J et al (2014) Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese. Int J Immunopathol Pharmacol 27:635\u2013638. https:\/\/doi.org\/10.1177\/039463201402700420","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4658_CR124","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","volume":"37","author":"W Zhao","year":"2017","unstructured":"Zhao W et al (2017) The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Rheumatol Int 37:1303\u20131310. https:\/\/doi.org\/10.1007\/s00296-017-3722-5","journal-title":"Rheumatol Int"},{"issue":"8","key":"4658_CR125","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15(8):509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"4658_CR126","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tig.2006.01.003","volume":"22","author":"VN Kim","year":"2006","unstructured":"Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22(3):165\u2013173. https:\/\/doi.org\/10.1016\/j.tig.2006.01.003","journal-title":"Trends Genet"},{"issue":"3","key":"4658_CR127","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1371\/journal.pbio.0030085","volume":"3","author":"J Brennecke","year":"2005","unstructured":"Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA\u2013target recognition. PLoS Biol 3(3):e85. https:\/\/doi.org\/10.1371\/journal.pbio.0030085","journal-title":"PLoS Biol"},{"key":"4658_CR128","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","volume":"89","author":"E Chouri","year":"2018","unstructured":"Chouri E, Servaas NH, Bekker CP, Affandi AJ, Cossu M, Hillen MR, Angiolilli C, Mertens JS, van den Hoogen LL, Silva-Cardoso S, van der Kroef M (2018) Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J Autoimmun 89:162\u2013170. https:\/\/doi.org\/10.1016\/j.jaut.2017.12.015","journal-title":"J Autoimmun"},{"issue":"6","key":"4658_CR129","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.2353\/ajpath.2008.071021","volume":"172","author":"E Hsu","year":"2008","unstructured":"Hsu E, Feghali-Bostwick CA (2008) Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase dependent pathways. Am J Pathol 172(6):1580\u20131590. https:\/\/doi.org\/10.2353\/ajpath.2008.071021","journal-title":"Am J Pathol"},{"issue":"1","key":"4658_CR130","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","volume":"18","author":"RB Christmann","year":"2016","unstructured":"Christmann RB, Wooten A, Sampaio-Barros P, Borges CL, Carvalho CR, Kairalla RA, Feghali-Bostwick C, Ziemek J, Mei Y, Goummih S, Tan J (2016) miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Res Ther 18(1):155. https:\/\/doi.org\/10.1186\/s13075-016-1054-6","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4658_CR131","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/03009742.2016.1167950","volume":"46","author":"Z Jiang","year":"2017","unstructured":"Jiang Z, Tao JH, Zuo T, Li XM, Wang GS, Fang X, Xu XL, Li XP (2017) The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases. Scand J Rheumatol 46(2):122\u2013129. https:\/\/doi.org\/10.3109\/03009742.2016.1167950","journal-title":"Scand J Rheumatol"},{"key":"4658_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2018.10.002","volume":"204","author":"M Vreca","year":"2018","unstructured":"Vreca M, Andjelkovic M, Tosic N, Zekovic A, Damjanov N, Pavlovic S, Spasovski V (2018) Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis. Immunol Lett 204:1\u20138. https:\/\/doi.org\/10.1016\/j.imlet.2018.10.002","journal-title":"Immunol Lett"},{"key":"4658_CR133","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ et al (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207:1589\u20131597. https:\/\/doi.org\/10.1084\/jem.20100035","journal-title":"J Exp Med"},{"key":"4658_CR134","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijcha.2015.06.006","volume":"8","author":"Y Izumiya","year":"2015","unstructured":"Izumiya Y, Jinnn M, Kimura Y, Wang Z, Onoue Y, Hanatani S, Araki S, Ihn H, Ogawa H (2015) Expression of Let-7 family microRNAs in skin correlates negatively with severity of pulmonary hypertension in patients with systemic scleroderma. IJC Heart Vasc 8:98\u2013102. https:\/\/doi.org\/10.1016\/j.ijcha.2015.06.006","journal-title":"IJC Heart Vasc"},{"issue":"1","key":"4658_CR135","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","volume":"61","author":"Y Kawashita","year":"2011","unstructured":"Kawashita Y, Jinnin M, Makino T, Kajihara I, Makino K, Honda N, Masuguchi S, Fukushima S, Inoue Y, Ihn H (2011) Circulating miR-29a levels in patients with scleroderma spectrum disorder. J Dermatol Sci 61(1):67\u201369. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.11.007","journal-title":"J Dermatol Sci"},{"key":"4658_CR136","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/annrheumdis-2014-205326","volume":"75","author":"N Iwamoto","year":"2016","unstructured":"Iwamoto N, Vettori S, Maurer B, BrockM Pachera E, J\u00fcngel A et al (2016) Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. Ann Rheum Dis 75:303\u2013310. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205326","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4658_CR137","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL (2019) Cellular functions of long noncoding RNAs. Nat Cell Biol 21(5):542\u2013551. https:\/\/doi.org\/10.1038\/s41556-019-0311-8","journal-title":"Nat Cell Biol"},{"key":"4658_CR138","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fimmu.2019.01100","volume":"10","author":"M Takata","year":"2019","unstructured":"Takata M, Pachera E, Frank-Bertoncelj M, Kozlova A, J\u00fcngel A, Whitfield ML, Assassi S, Calcagni M, de Vries-Bouwstra J, Huizinga TW, Kurreeman F (2019) OTUD6B-AS1 might be a novel regulator of apoptosis in systemic sclerosis. Front Immunol 10:1100. https:\/\/doi.org\/10.3389\/fimmu.2019.01100","journal-title":"Front Immunol"},{"issue":"4","key":"4658_CR139","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/annrheumdis-2019-216542","volume":"79","author":"CW Wasson","year":"2020","unstructured":"Wasson CW, Abignano G, Hermes H, Malaab M, Ross RL, Jimenez SA, Chang HY, Feghali-Bostwick CA, del Galdo F (2020) Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann Rheum Dis 79(4):507\u2013517. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216542","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4658_CR140","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11926-019-0877-y","volume":"21","author":"PS Tsou","year":"2019","unstructured":"Tsou PS (2019) Epigenetic control of scleroderma: current knowledge and future perspectives. Curr Rheumatol Rep 21(12):69. https:\/\/doi.org\/10.1007\/s11926-019-0877-y","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"4658_CR141","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar H, Bergman Y (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10(5):295\u2013304. https:\/\/doi.org\/10.1038\/nrg2540","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4658_CR142","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13148-019-0652-y","volume":"11","author":"PS Ramos","year":"2019","unstructured":"Ramos PS, Zimmerman KD, Haddad S, Langefeld CD, Medsger TA, Feghali-Bostwick CA (2019) Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets. Clin Epigenet 11(1):58. https:\/\/doi.org\/10.1186\/s13148-019-0652-y","journal-title":"Clin Epigenet"},{"key":"4658_CR143","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","volume":"74","author":"N Altorok","year":"2015","unstructured":"Altorok N, Tsou PS, Coit P, Khanna D, Sawalha AH (2015) Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann Rheum Dis 74:1612\u20131620. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205303","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4658_CR144","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","volume":"73","author":"C Dees","year":"2014","unstructured":"Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, Beyer C, Distler O, Schett G, Distler JH (2014) The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann Rheum Dis 73(6):1232\u20131239. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203194","journal-title":"Ann Rheum Dis"},{"key":"4658_CR145","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1755-1536-7-14","volume":"7","author":"E De Langhe","year":"2014","unstructured":"De Langhe E, Aznar-Lopez C, De Vooght V et al (2014) Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo. Fibrogenesis Tissue Repair 7:14. https:\/\/doi.org\/10.1186\/1755-1536-7-14","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"7472","key":"4658_CR146","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli RM, Zhang Y (2013) TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502(7472):472. https:\/\/doi.org\/10.1038\/nature12750","journal-title":"Nature"},{"key":"4658_CR147","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/exd.12767","volume":"24","author":"M Hattori","year":"2015","unstructured":"Hattori M et al (2015) Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts. Exp Dermatol 24:841\u2013846. https:\/\/doi.org\/10.1111\/exd.12767","journal-title":"Exp Dermatol"},{"issue":"3","key":"4658_CR148","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/ijms18030633","volume":"18","author":"S Zhang","year":"2017","unstructured":"Zhang S et al (2017) miR-30a as potential therapeutics by targeting TET1 through regulation of Drp-1 promoter hydroxymethylation in idiopathic pulmonary fibrosis. Int J Mol Sci 18(3):633. https:\/\/doi.org\/10.3390\/ijms18030633","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4658_CR149","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1042\/CS20150697","volume":"130","author":"IC Evans","year":"2016","unstructured":"Evans IC, Barnes JL, Garner IM, Pearce DR, Maher TM, Shiwen X, Renzoni EA, Wells AU, Denton CP, Laurent GJ, Abraham DJ (2016) Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis. Clin Sci 130(8):575\u2013586. https:\/\/doi.org\/10.1042\/CS20150697","journal-title":"Clin Sci"},{"issue":"4.2","key":"4658_CR150","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1667\/RR14587.1","volume":"188","author":"S Tharmalingam","year":"2017","unstructured":"Tharmalingam S, Sreetharan S, Kulesza AV, Boreham, Tai TC (2017) Low-dose ionizing radiation exposure, oxidative stress and epigenetic programing of health and disease. Radiat Res 188(4.2):525\u2013538. https:\/\/doi.org\/10.1667\/RR14587.1","journal-title":"Radiat Res"},{"issue":"3\u20134","key":"4658_CR151","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1947601913483767","volume":"4","author":"P Mart\u00ednez-Redondo","year":"2013","unstructured":"Mart\u00ednez-Redondo P, Vaquero A (2013) The diversity of histone versus nonhistone sirtuin substrates. Genes Chromosomes Cancer 4(3\u20134):148\u2013163. https:\/\/doi.org\/10.1177\/1947601913483767","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"4658_CR152","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1165\/rcmb.2016-0192OC","volume":"58","author":"H Chu","year":"2018","unstructured":"Chu H, Jiang S, Liu Q, Ma Y, Zhu X, Liang M, Shi X, Ding W, Zhou X, Zou H, Qian F (2018) Sirtuin1 protects against systemic sclerosis\u2013related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes. Am J Respir Cell Mol Biol 58(1):28\u201339. https:\/\/doi.org\/10.1165\/rcmb.2016-0192OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"43","key":"4658_CR153","doi-asserted-by":"publisher","first-page":"69321","DOI":"10.18632\/oncotarget.12504","volume":"7","author":"K Akamata","year":"2016","unstructured":"Akamata K, Wei J, Bhattacharyya M, Cheresh P, Bonner MY, Arbiser JL, Raparia K, Gupta MP, Kamp DW, Varga J (2016) SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis. Oncotarget 7(43):69321\u201369336. https:\/\/doi.org\/10.18632\/oncotarget.12504","journal-title":"Oncotarget"},{"issue":"5","key":"4658_CR154","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/gerona\/glw151","volume":"72","author":"ML Sosulski","year":"2017","unstructured":"Sosulski ML, Gongora R, Feghali-Bostwick C, Lasky JA, Sanchez CG (2017) Sirtuin 3 deregulation promotes pulmonary fibrosis. J Gerontol A Biol Sci Med Sci 72(5):595\u2013602. https:\/\/doi.org\/10.1093\/gerona\/glw151","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"4658_CR155","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1074\/jbc.RA118.007212","volume":"295","author":"S Maity","year":"2020","unstructured":"Maity S, Muhamed J, Sarikhani M, Kumar S, Ahamed F, Spurthi KM, Ravi V, Jain A, Khan D, Arathi BP, Desingu PA (2020) Sirtuin 6 deficiency transcriptionally up-regulates TGF-\u03b2 signaling and induces fibrosis in mice. J Biol Chem 295(2):415\u2013434. https:\/\/doi.org\/10.1074\/jbc.RA118.007212","journal-title":"J Biol Chem"},{"issue":"6","key":"4658_CR156","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1152\/ajplung.00473.2016","volume":"312","author":"AE Wyman","year":"2017","unstructured":"Wyman AE, Noor Z, Fishelevich R, Lockatell V, Shah NG, Todd NW, Atamas SP (2017) Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 312(6):945\u2013958. https:\/\/doi.org\/10.1152\/ajplung.00473.2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"4658_CR157","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/annrheumdis-2017-211501","volume":"77","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T, P\u00f6tter S, Zhang Y, Chen CW, Mallano T, Liang R (2018) The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis. Ann Rheum Dis 77(1):150\u2013158. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211501","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"4658_CR158","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.14814\/phy2.12915","volume":"4","author":"X Xiao","year":"2016","unstructured":"Xiao X, Senavirathna LK, Gou X, Huang C, Liang Y, Liu L (2016) EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis. Physiol Rep 4(17):e12915. https:\/\/doi.org\/10.14814\/phy2.12915","journal-title":"Physiol Rep"},{"key":"4658_CR159","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0092-8674(83)90040-5","volume":"33","author":"BT Pan","year":"1983","unstructured":"Pan BT, Johnstone RM (1983) Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:967\u2013978","journal-title":"Cell"},{"issue":"2","key":"4658_CR160","first-page":"256","volume":"35","author":"C Harding","year":"1984","unstructured":"Harding C, Heuser J, Stahl P (1984) Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 35(2):256\u2013263","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"4658_CR161","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"SE Andaloussi","year":"2013","unstructured":"Andaloussi SE, M\u00e4ger I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12(5):347\u2013357. https:\/\/doi.org\/10.1038\/nrd3978","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4658_CR162","doi-asserted-by":"publisher","first-page":"L977","DOI":"10.1152\/ajplung.00546.2018","volume":"316","author":"MJ McVey","year":"2019","unstructured":"McVey MJ, Maishan M, Blokland KE, Bartlett N, Kuebler WM (2019) Extracellular vesicles in lung health, disease, and therapy. Am J Physiol Lung Cell Mol Physiol 316(6):L977\u2013L989. https:\/\/doi.org\/10.1152\/ajplung.00546.2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"4658_CR163","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9(1):19. https:\/\/doi.org\/10.1186\/s13578-019-0282-2","journal-title":"Cell Biosci"},{"issue":"3","key":"4658_CR164","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/09537100701882038","volume":"19","author":"S Nomura","year":"2008","unstructured":"Nomura S, Inami N, Ozaki Y, Kagawa H, Sv Fukuhara (2008) Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia. Platelets 19(3):192\u2013198. https:\/\/doi.org\/10.1080\/09537100701882038","journal-title":"Platelets"},{"issue":"451","key":"4658_CR165","doi-asserted-by":"publisher","first-page":"eaao3089","DOI":"10.1126\/scitranslmed.aao3089","volume":"10","author":"N Maugeri","year":"2018","unstructured":"Maugeri N, Capobianco A, Rovere-Querini P, Ramirez GA, Tombetti E, Della Valle P, Monno A, D\u2019Alberti V, Gasparri AM, Franchini S, D\u2019Angelo A (2018) Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis. Sci Transl Med 10(451):eaao3089. https:\/\/doi.org\/10.1126\/scitranslmed.aao3089","journal-title":"Sci Transl Med"},{"issue":"7","key":"4658_CR166","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/resp.13500","volume":"24","author":"MR Lammi","year":"2019","unstructured":"Lammi MR, Saketkoo LA, Okpechi SC, Ghonim MA, Wyczechowska D, Bauer N, Pyakurel K, Saito S, deBoisblanc BP, Boulares AH (2019) Microparticles in systemic sclerosis: potential pro-inflammatory mediators and pulmonary hypertension biomarkers. Respirology 24(7):675\u2013683. https:\/\/doi.org\/10.1111\/resp.13500","journal-title":"Respirology"},{"issue":"1","key":"4658_CR167","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12891-015-0653-8","volume":"16","author":"LV Iversen","year":"2015","unstructured":"Iversen LV, Ullman S, \u00d8stergaard O, Nielsen CT, Halberg P, Karlsmark T, Heegaard NH, Jacobsen S (2015) Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis. BMC Musculoskelet Disord 16(1):191. https:\/\/doi.org\/10.1186\/s12891-015-0653-8","journal-title":"BMC Musculoskelet Disord"},{"key":"4658_CR168","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/01902148.2013.784932","volume":"39","author":"T Takahashi","year":"2013","unstructured":"Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, Tando Y et al (2013) Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro. Exp Lung Res 39:155\u2013161. https:\/\/doi.org\/10.3109\/01902148.2013.784932","journal-title":"Exp Lung Res"},{"issue":"6","key":"4658_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0255-x","volume":"51","author":"MY Yao","year":"2019","unstructured":"Yao MY, Zhang WH, Ma WT, Liu QH, Xing LH, Zhao G (2019) microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model. Exp Mol Med 51(6):1\u20136. https:\/\/doi.org\/10.1038\/s12276-019-0255-x","journal-title":"Exp Mol Med"},{"issue":"7","key":"4658_CR170","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/art.39121","volume":"67","author":"N Kavian","year":"2015","unstructured":"Kavian N, Marut W, Servettaz A, Nicco C, Ch\u00e9reau C, Lemar\u00e9chal H, Guilpain P, Chimini G, Galland F, Weill B, Naquet P (2015) Pantethine prevents murine systemic sclerosis through the inhibition of microparticle shedding. Arthritis Rheumatol 67(7):1881\u20131890. https:\/\/doi.org\/10.1002\/art.39121","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4658_CR171","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345. https:\/\/doi.org\/10.1038\/nbt.1807","journal-title":"Nat Biotechnol"},{"issue":"2","key":"4658_CR172","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/mt.2010.254","volume":"19","author":"Y Akao","year":"2011","unstructured":"Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, Naoe T (2011) Microvesicle-mediated RNA molecule delivery system using monocytes\/macrophages. Mol Ther 19(2):395\u2013399. https:\/\/doi.org\/10.1038\/mt.2010.254","journal-title":"Mol Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04658-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04658-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04658-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T23:14:25Z","timestamp":1627254865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04658-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,26]]},"references-count":172,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4658"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04658-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,26]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not include any human participants and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}